Hematology NewsVIDEO: Anticoagulant underprescribing common, jeopardizing atrial fib patientsJanuary 16, 2018Preventive CareThrombosis
Hematology TimesEmicizumab still available despite legal issuesJanuary 14, 2018ThrombosisPharmacyBleeding Disorders
Hematology TimesCaplacizumab improves outcomes in aTTPJanuary 5, 2018AnemiaThrombosisBleeding Disorders
Hematology TimesFDA lifts clinical hold on fitusiran trialsDecember 19, 2017ThrombosisBleeding Disorders
Hematology NewsVTE rates in lenalidomide-treated NHL may warrant prophylaxisDecember 12, 2017ThrombosisAggressive LymphomasLymphoma & Plasma Cell Disorders
Oncology PracticeEdoxaban noninferior to dalteparin for cancer-associated VTEDecember 12, 2017ThrombosisPatient & Survivor Care
Hematology TimesEmicizumab reduces bleeds in kids with hemophilia A and inhibitorsDecember 11, 2017ThrombosisPediatricsBleeding Disorders
Hematology NewsGuideline preview: ASH to recommend against VTE prophylaxis for lower-risk cancer patientsDecember 10, 2017Thrombosis
Hematology NewsPoststroke depression raises risk of cerebrovascular death 35-foldDecember 8, 2017Thrombosis
Hematology TimesGene therapy seems safe, effective in hemophilia BDecember 7, 2017ThrombosisBleeding Disorders
